Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Some women who develop high blood pressure during pregnancy, such as gestational hypertension or preeclampsia, may continue to have slightly or moderately high blood pressure after giving birth. This can increase their risk of heart disease later in life. Managing blood pressure and adopting a healthy lifestyle after pregnancy could help lower this risk.
Right now, the investigators don't know much about how postpartum rehabilitation programs focused on heart and pregnancy-related health could help women with these conditions. However, a feasibility study suggests that exercise programs might help reduce blood pressure and encourage healthier lifestyles in these women.
In this study, the investigators are testing an 8-week exercise program to see how it affects blood pressure, fitness, and blood vessel health. The investigators will compare the results with a group of women who receive usual healthcare, which includes verbal advice on healthy living but no supervised exercise sessions.
This type of program, called cardio-obstetric rehabilitation, combines exercises for heart health with specialized care for women's health.
Women with severe hypertensive disorders during pregnancy, such as preeclampsia (PE), have a higher risk of heart disease and stroke within five to 10 years of their pregnancy. Because their blood pressure (BP) drops in the postpartum period in comparison to the values they had during pregnancy, the hypertensive disorder can be considered resolved. However, recent studies have shown that their postpartum BP may be higher than before pregnancy. Hypertensive pregnancy has been associated with endothelial and microvascular dysfunction and capillary rarefaction, which could be the key mechanism leading to elevated BP in the postpartum period. Studies have shown that physical exercise promotes BP reduction, stimulates angiogenesis and improves microcirculation in healthy subjects, but also in patients with cardiovascular and metabolic diseases. Therefore, interventions to better monitor BP combined with a healthy lifestyle could help reduce the risk of heart disease in later years. The effects of postpartum cardio-obstetric rehabilitation in women with gestational hypertension (GH) or PE are still unknown. It is of interest to determine whether a postpartum cardio-obstetric rehabilitation program could reduce BP, identifying the possible mechanisms, and stimulate the adoption of a healthy lifestyle with potential long-term health benefits for women.
The main objective of this study is to describe the effects of an 8-week rehabilitation program combining aerobic exercise with obstetric rehabilitation starting between 3 to 6 months postpartum on BP changes, vascular structure and physical activity levels, which could lead to long term health benefits compared to usual care in women with previous GH and PE. The 8-week rehabilitation program will include cardiac (aerobic exercise) and obstetric (pelvic floor training, core and balance) exercises, as well as online education courses about healthy lifestyle. The outcomes will be compared with participants submitted to the usual care in the postpartum. At the end of the study participation period, participants of the control group will be offered to participate in the intervention program (crossing study).
The following outcomes will be evaluated, before and immediately after the intervention: ambulatory and 24-hour BP, arterial stiffness, pulse wave velocity, static retinal vessels analysis, body composition (including body mass index), physical capacity (6-minute walk test), physical activity level (number of daily steps), lipid and glucose profiles, quality of life (SF-36), as well as plasmatic angiogenic biomarkers and the angiogenic function of circulating endothelial cells. Moreover, 6-months post-intervention, participants will be submitted again only to physical evaluation to assess the long-term effects of the intervention program.
Cardio-obstetric rehabilitation is a new field, lacking the description and evaluation of effective programs. The investigators expect that the results obtained from this study will contribute to the design of a patient-oriented rehabilitation program. Our findings will provide the first evidence to support postpartum rehabilitation services in clinics which in turn could lead to long term health benefits to women.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Rehabilitation Group | Experimental | The rehabilitation Group will be submitted to an 8-week exercise and education program with a hybrid format, delivered by a professional physiotherapist at the Centre Jean-Jacques Gauthier (CJJG). Briefly, one in-person session (60 minutes of aerobic exercise and full-body strength exercise), one online session (30-35 minutes - focus on pelvic floor muscle training, core/abdominals, balance, and stretching exercises), and one pre-recorded video (30 minutes - exercise instructions) will be delivered per week. Participants will use Fitbit Charge-6 to progressively reach daily 10,000 steps throughout the intervention period. Four online educational workshops on healthy lifestyle will be delivered. |
|
| Control group | No Intervention | Control group participants will received the usual care, together with information about the guidelines for physical activity practice, nutritional and risk factor monitoring instructions, pelvic floor exercise instructions, and recommendations to progressively reach daily 10,000 steps according to guidelines . Participants will also receive a Fitbit device. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Postpartum Cardio-obstetric Rehabilitation Program | Other | The intervention consists of an 8-week exercise and education program with a hybrid format (in person, virtual and pre-recorded sessions). The aerobic exercise intensity will progressively increase from 50 to 85% of Targeted Heart Rate Range (THRR), calculated for middle-aged women using the maximal heart rate (HR) estimated as 206 - (0.88 x age) . First and second weeks training will target an intensity of 50-65% THRR, third and fourth weeks will target 65 to 75% of THRR, fifth to seventh weeks will target 75 to 80%, and eighth week will target 85%. Participants will use Fitbit Charge-6 to monitor THRR during exercise sessions. Pelvic floor, body alignment/core stability, balance, and low back pain prevention exercises will be added to each in-person session and repeated during the online session. Participants from the intervention group will receive recommendations to progressively reach daily 10,000 steps throughout the intervention period. |
| Measure | Description | Time Frame |
|---|---|---|
| Office Blood Pressure | Resting office BP will be measured with the patient in the sitting position after 5 minutes at rest using a validated automated sphygmomanometer according to established practice guidelines . Three readings will be taken at intervals of 2 minutes. | Baseline, immediately post-intervention, and 6-month post-intervention |
| 24-hour Ambulatory Blood Pressure | 24-hour Ambulatory Blood Pressure using OSCAR 2 equipment. | Baseline, immediately post-intervention, and 6-month post-intervention |
| Measure | Description | Time Frame |
|---|---|---|
| Static Retinal Vascular Analysis | Retinal microvasculature imaging will be taken using Static Vessel Analyzer (SVA-T, Imedos) through non-invasive procedures described by Hanssen's team . | Baseline, immediately post-intervention, and 6-month post-intervention |
| Peripheral artery stiffness - PWV |
| Measure | Description | Time Frame |
|---|---|---|
| SF-36 Quality of Life Questionnaire (SF-36). | Health status will be evaluated based on: SF-36 Quality of Life Questionnaire (SF-36). | Baseline, immediately post-intervention, and 6-month post-intervention |
| Patient Health Questionnaire-9 (PHQ-9) |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Mariane Bertagnolli, PhD, Professor | Contact | 514-388-2222 | 2501 | mariane.bertagnolli.cnmtl@ssss.gouv.qc.ca |
| Rafael O Fernandes, PhD | Contact | rafael.fernandes@muhc.mcgill.ca |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hôpital du Sacre-Coer de Montréal - CIUSSS du Nord-de-l'Île-de-Montréal | Montreal | Quebec | Canada |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 26103803 | Background | Visser VS, Hermes W, Franx A, Koopmans CM, van Pampus MG, Mol BW, de Groot CJ. High blood pressure six weeks postpartum after hypertensive pregnancy disorders at term is associated with chronic hypertension. Pregnancy Hypertens. 2013 Oct;3(4):242-7. doi: 10.1016/j.preghy.2013.07.002. Epub 2013 Aug 9. | |
| 33971204 | Background |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D046110 | Hypertension, Pregnancy-Induced |
| D011225 | Pre-Eclampsia |
| D009043 | Motor Activity |
| ID | Term |
|---|---|
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D006973 | Hypertension |
Not provided
Not provided
Not provided
Not provided
Not provided
The research team that will evaluate the participants will be blind to the group - intervention or control (conventional care).
|
Peripheral artery stiffness will be measured using SphygmoCor XCEL system through pulse wave velocity (PWV) as described by Daskalopoulou's team. |
| Baseline, immediately post-intervention, and 6-month post-intervention |
| Peripheral artery stiffness - PWA | The Sphygmocor XCEL system will be used to assess arterial stiffness through Pulse Wave Analysis (PWA), according to the instruction guidelines. | Baseline, immediately post-intervention, and 6-month post-intervention |
| Physical capacity (6MWT) | Six-minute walk test will be performed following the protocol described by the American Thoracic Society. | Baseline, immediately post-intervention, and 6-month post-intervention |
| Physical activity levels | All participants will receive a wrist worn heart rate and accelerometer monitor (Fitbit Charge 6). This device will be used to monitor physical activity levels (total steps per week) and targeted heart rates during exercise training. | Baseline, immediately post-intervention, and 6-month post-intervention |
| Body composition | Body composition will be measure using a bioimpedance scale InBody 570. | Baseline, immediately post-intervention, and 6-month post-intervention |
| Timed Up and Go (TUG) | TUG test: The objective of TUG test is to assess mobility, balance and fall-risk. It consists of the participant stand-up from a chair, walk 3 meters, turn, walk back and sit down again. Interpretation: test performed ≤10 seconds indicates normal mobility. | Baseline, immediately post-intervention, and 6-month post-intervention |
| Handgrip strength | The maximal handgrip strength will be performed using a manual Jamar Hydraulic Hand Dynamometer. | Baseline, immediately post-intervention, and 6-month post-intervention |
| Glucose | Blood draw by venipuncture will be collected to measure glucose at the Biochemistry laboratory of the MUHC. | Baseline, immediately post-intervention, and 6-month post-intervention |
| Angiogenic and proliferative function of peripheral blood ECFCs | Endothelial cell function will be assessed by the procedures described by Bertagnolli's team . ECFCs = Endothelial colony forming cell | Baseline, immediately post-intervention, and 6-month post-intervention |
| Plasmatic levels of angiogenic factors - VEGF | Serum concentration of angiogenic factors by ELISA following manufacturer instructions - Vascular endothelial growth factor (VEGF) | Baseline, immediately post-intervention, and 6-month post-intervention |
| Heart rate variability | R-R intervals will be recorded using a Vantage V2 Polar heart rate monitor at a sampling rate of 1,000 Hz. HRV will be recorded during deep breathing maneuver (continuous cycles) for 4 min in a supine position. HRV will be analyzed using Kubios HRV software following guidelines from the Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. | Baseline, immediately post-intervention, and 6-month post-intervention |
| Circulating Endothelial Cells (cEC) Function | cEC tube formation capacity on matrigel, proliferation, and migration capacities. | Baseline, immediately post-intervention, and 6-month post-intervention |
| Total cholesterol | Blood draw by venipuncture will be collected to measure total cholesterol at the Biochemistry laboratory of the MUHC. | Baseline, immediately post-intervention, and 6-month post-intervention |
| Insuline | Blood draw by venipuncture will be collected to measure total cholesterol at the Biochemistry laboratory of the MUHC. | Baseline, immediately post-intervention, and 6-month post-intervention |
| Glycated hemoglobin (HbA1c) | Blood draw by venipuncture will be collected to measure HbA1c at the Biochemistry laboratory of the MUHC. | Baseline, immediately post-intervention, and 6-month post-intervention |
| LDL cholesterol | Blood draw by venipuncture will be collected to measure LDL-cholesterol at the Biochemistry laboratory of the MUHC. | Baseline, immediately post-intervention, and 6-month post-intervention |
| HDL cholesterol | Blood draw by venipuncture will be collected to measure HDL cholesterol at the Biochemistry laboratory of the MUHC. | Baseline, immediately post-intervention, and 6-month post-intervention |
| Triglycerides | Blood draw by venipuncture will be collected to measure triglycerides at the Biochemistry laboratory of the MUHC. | Baseline, immediately post-intervention, and 6-month post-intervention |
| Brain Natriuretic Peptide (NT-PRO-BNP) | Blood draw by venipuncture will be collected to measure NT-PRO-BNP at the Biochemistry laboratory of the MUHC. | Baseline, immediately post-intervention, and 6-month post-intervention |
| C-reactive protein (CRP) | Blood draw by venipuncture will be collected to measure C-reactive protein (CRP) at the Biochemistry laboratory of the MUHC. | Baseline, immediately post-intervention, and 6-month post-intervention |
| Plasmatic levels of angiogenic factors - NO | Serum concentration of angiogenic factors by ELISA following manufacturer instructions - Nitric Oxide (NO). | Baseline, immediately post-intervention, and 6-month post-intervention |
Health status will be evaluated based on: Patient Health Questionnaire-9 (PHQ-9) for depression symptoms
| Baseline, immediately post-intervention, and 6-month post-intervention |
| Edinburgh Postnatal Depression Scale (EPDS). | Health status will be evaluated based on: Edinburgh Postnatal Depression Scale (EPDS). | Baseline, immediately post-intervention, and 6-month post-intervention |
| Pittsburgh Sleep Quality Index (PSQI). | Health status will be evaluated based on: Pittsburgh Sleep Quality Index (PSQI). | Baseline, immediately post-intervention, and 6-month post-intervention |
| Pregnancy Physical Activity Questionnaire (PPAQ). | Physical activity will be also evaluated based on Pregnancy Physical Activity Questionnaire (PPAQ). | Baseline, immediately post-intervention, and 6-month post-intervention |
| Duke Activity Status Index (DASI) | Physical activity will be also evaluated based on Duke Activity Status Index (DASI) | Baseline, immediately post-intervention, and 6-month post-intervention |
| International Physical Activity Questionnaire (IPAQ). | Physical activity will be also evaluated based on International Physical Activity Questionnaire (IPAQ). | Baseline, immediately post-intervention, and 6-month post-intervention |
| Pelvic Floor Distress Inventory (PFDI-20) | Pelvic health will be evaluated by Pelvic Floor Distress Inventory (PFDI-20) | Baseline, immediately post-intervention, and 6-month post-intervention |
| Urogenital Distress Inventory (UDI) | Pelvic health will be evaluated by Urogenital Distress Inventory (UDI). | Baseline, immediately post-intervention, and 6-month post-intervention |
| Pelvic Floor Impact Questionnaire (PFIQ-7). | Pelvic health will be evaluated by Pelvic Floor Impact Questionnaire (PFIQ-7). | Baseline, immediately post-intervention, and 6-month post-intervention |
| Phan K, Schiller I, Dendukuri N, Gomez YH, Gorgui J, El-Messidi A, Gagnon R, Daskalopoulou SS. A longitudinal analysis of arterial stiffness and wave reflection in preeclampsia: Identification of changepoints. Metabolism. 2021 Jul;120:154794. doi: 10.1016/j.metabol.2021.154794. Epub 2021 May 8. |
| 26104418 | Background | Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P; Canadian Hypertensive Disorders of Pregnancy (HDP) Working Group. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. Pregnancy Hypertens. 2014 Apr;4(2):105-45. doi: 10.1016/j.preghy.2014.01.003. Epub 2014 Feb 25. |
| 16531805 | Background | Lampinen KH, Ronnback M, Kaaja RJ, Groop PH. Impaired vascular dilatation in women with a history of pre-eclampsia. J Hypertens. 2006 Apr;24(4):751-6. doi: 10.1097/01.hjh.0000217859.27864.19. |
| 30343979 | Background | Davenport MH, Ruchat SM, Mottola MF, Davies GA, Poitras VJ, Gray CE, Garcia AJ, Barrowman N, Adamo KB, Duggan M, Barakat R, Chilibeck P, Fleming K, Forte M, Korolnek J, Nagpal T, Slater LG, Stirling D, Zehr L. 2019 Canadian Guideline for Physical Activity Throughout Pregnancy: Methodology. J Obstet Gynaecol Can. 2018 Nov;40(11):1468-1483. doi: 10.1016/j.jogc.2018.09.004. Epub 2018 Oct 18. No abstract available. |
| 17975258 | Background | Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007 Nov 10;335(7627):974. doi: 10.1136/bmj.39335.385301.BE. Epub 2007 Nov 1. |
| 28170188 | Background | Bertagnolli M, Nuyt AM, Thebaud B, Luu TM. Endothelial Progenitor Cells as Prognostic Markers of Preterm Birth-Associated Complications. Stem Cells Transl Med. 2017 Jan;6(1):7-13. doi: 10.5966/sctm.2016-0085. Epub 2016 Jul 27. |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D001519 | Behavior |